This was reported in the operational headquarters.

Earlier, Academician of the Russian Academy of Sciences Gennady Onishchenko, in an interview with the FAN, recalled the importance of revaccination against COVID-19.

On August 23, the Ministry of Health of Russia registered a new drug against coronavirus, Molnupiravir Valenta, in the form of 200 mg capsules, which was developed by Valenta Pharm.